A HIGH THROUGHPUT ASSAY FOR INHIBITORS OF HIV-1 PROTEASE - SCREENING OF MICROBIAL METABOLITES

被引:19
作者
SARUBBI, E [1 ]
NOLLI, ML [1 ]
ANDRONICO, F [1 ]
STELLA, S [1 ]
SADDLER, G [1 ]
SELVA, E [1 ]
SICCARDI, A [1 ]
DENARO, M [1 ]
机构
[1] UNIV MILAN,DIPARTIMENTO BIOL & GENET,I-20122 MILAN,ITALY
关键词
HUMAN IMMUNODEFICIENCY VIRUS; PROTEINASE; FUSION PROTEIN; IMMUNOLOGICAL ASSAY; MICROBIAL ALKALINE PROTEASE INHIBITOR;
D O I
10.1016/0014-5793(91)80164-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel method for discovery of HIV-1 protease inhibitors in complex biological samples has been developed. The assay is based on two specific reagents: a recombinant protein constituted by a portion of the HIV-1 Gag polyprotein comprising the p17-p24 cleavage site, fused to E. coli beta-galactosidase, and a monoclonal antibody which binds the fusion protein in the Gag region. Binding occurs only if the fusion protein has not been cleaved by the HIV-1 protease. The assay has been adapted for the screening of large numbers of samples in standard 96-well microtiter plates. Using this method about 12000 microbial fermentation broths have been tested and several HIV-1 protease inhibitory activities have been detected. One of these has been studied in detail.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 32 条
[1]   PURIFICATION, ASSAY AND KINETIC FEATURES OF HIV-1 PROTEINASE [J].
BILLICH, A ;
HAMMERSCHMID, F ;
WINKLER, G .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (03) :265-272
[2]   THE 3-D STRUCTURE OF HIV-1 PROTEINASE AND THE DESIGN OF ANTIVIRAL AGENTS FOR THE TREATMENT OF AIDS [J].
BLUNDELL, TL ;
LAPATTO, R ;
WILDERSPIN, AF ;
HEMMINGS, AM ;
HOBART, PM ;
DANLEY, DE ;
WHITTLE, PJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1990, 15 (11) :425-430
[3]   HIV-1 PROTEASE SPECIFICITY OF PEPTIDE CLEAVAGE IS SUFFICIENT FOR PROCESSING OF GAG AND POL POLYPROTEINS [J].
DARKE, PL ;
NUTT, RF ;
BRADY, SF ;
GARSKY, VM ;
CICCARONE, TM ;
LEU, CT ;
LUMMA, PK ;
FREIDINGER, RM ;
VEBER, DF ;
SIGAL, IS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 156 (01) :297-303
[4]   INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE INVITRO - RATIONAL DESIGN OF SUBSTRATE-ANALOG INHIBITORS [J].
DREYER, GB ;
METCALF, BW ;
TOMASZEK, TA ;
CARR, TJ ;
CHANDLER, AC ;
HYLAND, L ;
FAKHOURY, SA ;
MAGAARD, VW ;
MOORE, ML ;
STRICKLER, JE ;
DEBOUCK, C ;
MEEK, TD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9752-9756
[5]   MiniReview: Antiviral Targets Series, Number 1 Targets for antiviral chemotherapy: HIV-proteinase [J].
Dunn, B. M. ;
Kay, J. .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1990, 1 (01) :3-8
[6]   DESIGN, ACTIVITY, AND 2.8 A CRYSTAL-STRUCTURE OF A C2 SYMMETRICAL INHIBITOR COMPLEXED TO HIV-1 PROTEASE [J].
ERICKSON, J ;
NEIDHART, DJ ;
VANDRIE, J ;
KEMPF, DJ ;
WANG, XC ;
NORBECK, DW ;
PLATTNER, JJ ;
RITTENHOUSE, JW ;
TURON, M ;
WIDEBURG, N ;
KOHLBRENNER, WE ;
SIMMER, R ;
HELFRICH, R ;
PAUL, DA ;
KNIGGE, M .
SCIENCE, 1990, 249 (4968) :527-533
[7]   FLUORESCENCE-BASED CONTINUOUS ASSAY FOR THE ASPARTYL PROTEASE OF HUMAN IMMUNODEFICIENCY VIRUS-1 [J].
GEOGHEGAN, KF ;
SPENCER, RW ;
DANLEY, DE ;
CONTILLO, LG ;
ANDREWS, GC .
FEBS LETTERS, 1990, 262 (01) :119-122
[8]   HIV-1 PROTEASE - MUTAGENESIS OF ASPARAGINE-88 INDICATES A DOMAIN REQUIRED FOR DIMER FORMATION [J].
GUENET, C ;
LEPPIK, RA ;
PELTON, JT ;
MOELLING, K ;
LOVENBERG, W ;
HARRIS, BA .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1989, 172 (06) :443-451
[9]   HIV-1 aspartic proteinase: high-level production and automated fluorometric screening assay of inhibitors [J].
Hirel, Ph-H ;
Parker, F. ;
Boiziau, J. ;
Jung, G. ;
Outerovitch, D. ;
Dugue, A. ;
Peltiers, C. ;
Giuliacci, C. ;
Boulay, R. ;
Lelievre, Y. ;
Cambou, B. ;
Mayaux, J-F ;
Cartwright, T. .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1990, 1 (01) :9-15
[10]   A RADIOMETRIC ASSAY FOR HIV-1 PROTEASE [J].
HYLAND, LJ ;
DAYTON, BD ;
MOORE, ML ;
SHU, AYL ;
HEYS, JR ;
MEEK, TD .
ANALYTICAL BIOCHEMISTRY, 1990, 188 (02) :408-415